StockMarketWire.com - Credit Suisse today reaffirms its neutral investment rating on GlaxoSmithKline PLC [LON:GSK] and cut its price target to 1700p (from 1860p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk